Chris Javadi, MD, PhD

Fellow
Stanford
Stanford, California, United States

Dr. Chris Javadi is the inaugural surgical oncology fellow at Stanford. He obtained his MD and PhD in 2015 at the University of Texas Southwestern Medical Center. He completed general surgery residency at Stanford in 2020. His research interests include outcomes analysis following multidisciplinary treatment of hepatic, pancreatic, and gastrointestinal malignancies. After completing fellowship in 2022, he will join the Palo Alto Medical Foundation as a surgical oncologist.

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 41: Radiographic, Biochemical, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which Is Best?

  Thursday, March 10, 2022
  3:51 PM – 3:59 PM CST

• 41: Q&A

  Thursday, March 10, 2022
  3:59 PM – 4:01 PM CST